These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Protection mechanisms against aberrant metabolism of sphingolipids in budding yeast. Tani M; Funato K Curr Genet; 2018 Oct; 64(5):1021-1028. PubMed ID: 29556757 [TBL] [Abstract][Full Text] [Related]
28. Use of fluorescent sphingolipid analogs to study lipid transport along the endocytic pathway. Marks DL; Singh RD; Choudhury A; Wheatley CL; Pagano RE Methods; 2005 Jun; 36(2):186-95. PubMed ID: 15905102 [TBL] [Abstract][Full Text] [Related]
29. Molecular facets of sphingolipids: mediators of diseases. Ozbayraktar FB; Ulgen KO Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220 [TBL] [Abstract][Full Text] [Related]
30. Compartmentalization of Sphingolipid metabolism: Implications for signaling and therapy. Canals D; Clarke CJ Pharmacol Ther; 2022 Apr; 232():108005. PubMed ID: 34582834 [TBL] [Abstract][Full Text] [Related]
31. Assessment of crosstalks between the Snf1 kinase complex and sphingolipid metabolism in S. cerevisiae via systems biology approaches. Borklu Yucel E; Ulgen KO Mol Biosyst; 2013 Nov; 9(11):2914-31. PubMed ID: 24056632 [TBL] [Abstract][Full Text] [Related]
32. Combining Deep Sequencing, Proteomics, Phosphoproteomics, and Functional Screens To Discover Novel Regulators of Sphingolipid Homeostasis. Lebesgue N; Megyeri M; Cristobal A; Scholten A; Chuartzman SG; Voichek Y; Scheltema RA; Mohammed S; Futerman AH; Schuldiner M; Heck AJ; Lemeer S J Proteome Res; 2017 Feb; 16(2):571-582. PubMed ID: 28152593 [TBL] [Abstract][Full Text] [Related]
33. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches. Burns TA; Luberto C Anticancer Agents Med Chem; 2011 Nov; 11(9):863-81. PubMed ID: 21707485 [TBL] [Abstract][Full Text] [Related]
36. Phospholipid and sphingolipid metabolism in Leishmania. Zhang K; Beverley SM Mol Biochem Parasitol; 2010 Apr; 170(2):55-64. PubMed ID: 20026359 [TBL] [Abstract][Full Text] [Related]
37. Development of structural organization of protein-synthesizing machinery from prokaryotes to eukaryotes. Ryazanov AG; Ovchinnikov LP; Spirin AS Biosystems; 1987; 20(3):275-88. PubMed ID: 3113506 [TBL] [Abstract][Full Text] [Related]
38. Neuronal membrane dynamics as fine regulator of sphingolipid composition. Aureli M; Samarani M; Loberto N; Chiricozzi E; Mauri L; Grassi S; Schiumarini D; Prinetti A; Sonnino S Glycoconj J; 2018 Aug; 35(4):397-402. PubMed ID: 30145639 [TBL] [Abstract][Full Text] [Related]
40. Sphingolipids are essential for differentiation but not growth in Leishmania. Zhang K; Showalter M; Revollo J; Hsu FF; Turk J; Beverley SM EMBO J; 2003 Nov; 22(22):6016-26. PubMed ID: 14609948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]